Avita serves up a $23m raise but goes shy on co-manager
SYDNEY: Avita Medical shareholders were left wide-eyed after the dual-listed biotech, known for its spray-on
SYDNEY: Avita Medical shareholders were left wide-eyed after the dual-listed biotech, known for its spray-on